Impact of oral azithromycin on recurrence of trachomatous trichiasis in Nepal over 1 year

British Journal of Ophthalmology

Volumn 90, Issue 8, 2006, Pages 943-948

  Zhang, H ^a   Kandel, R P ^b   Atakari, H K ^b   Dean, Deborah ^a,c  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^b Lumbini Rana Ambika Eye Hospital   (Nepal)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; PLACEBO;

ADULT; AGED; ARTICLE; CHLAMYDIA TRACHOMATIS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INFECTION RATE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEPAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; RECURRENT DISEASE; REDUCTION; TRICHIASIS;

ADMINISTRATION, ORAL; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; AZITHROMYCIN; COMBINED MODALITY THERAPY; DEVELOPING COUNTRIES; DOUBLE-BLIND METHOD; EYELID DISEASES; FEMALE; FOLLOW-UP STUDIES; HAIR DISEASES; HUMANS; MALE; MIDDLE AGED; NEPAL; RECURRENCE; SEVERITY OF ILLNESS INDEX; TRACHOMA;

EID: 33746580349     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2006.093104     Document Type: Article

References (28)

1. Dean D. Pathogenesis of chlamydial ocular infections. In Tasman W, Jaeger EA, eds. Duane's foundations of clinical ophthalmology. Philadelphia: Lippincott Williams & Wilkins, 2002:1-22.
2. Khandekar R, Mohammed AJ, Courtright P. Recurrence of trichiasis: a long-term follow-up study in the Sultanate of Oman. Ophthalmic Epidemiol 2001;8:155-61.
3. Rabiu AAM, Abiose A. Magnitude of trachoma and barriers to uptake of lid surgery in a rural community of northern Nigeria. Ophthalmic Epidemiol 2001;8:181-90.
4. West SK, Rapoza P, Munoz, et al. Epidemiology of ocular chlamydial infection in a trachoma-hyperendemic area. J Infect Dis 1991;163:752-6.
5. Muñoz B, Bobo L, Mkocha H, et al. Incidence of trichiasis in a cohort of women with and without scarring. Int J Epidemiol 1999;28:1167-71.
6. World Health Organization. Report of the First Meeting of the WHO Alliance for the Global Elimination of Trachoma. Geneva: WHO, 30 June-1 July, 1997:1-22.
7. Reacher MH, Munoz B, Alghassany A, et al. A controlled trial of surgery for trachomatous trichiasis of the upper lid. Arch Ophthalmol 1992;110:667-74.
8. Reacher MH, Foster A, Huber J. Trichiasis surgery for trachoma: the bilamellar tarsal rotation procedure. WHO/PBL/93.29. Geneva: World Health Organization, 1993:1-10.
9. World Health Organization. Report of the third meeting of the WHO alliance for the global elimination of trachoma. Geneva: WHO, December, 1999:1-15.
10. Bailey R, Lietman T. The SAFE strategy for the elimination of trachoma by 2020: will it work? Bull World Health Organ 2001;79:233-6.
11. Bog H, Yorston D, Foster A. Results of community-based eyelid surgery for trichiasis due to trachoma. Br J Ophthalmol 1993;77:81-3.
12. Thanh TT, Khandekar R, Luong VQ, et al. One year recurrence of trachomatous trichiasis in routinely operated Cuenod Nataf procedure cases in Vietnam. Br J Ophthalmol 2004;88:1114-18.
13. Zhang H, Kandel RP, Sharma B, et al. Risk factors for recurrence of postoperative trichiasis: implications for trachoma blindness prevention. Arch Ophthalmol 2004;122:511-6.
14. Dawson CR, Jones BR, Tarizzo ML. Guide to trachoma control. Geneva: World Health Organization, 1981:9-20.
15. Schachter J, West SK, Mabey D, et al. Azithromycin in control of trachoma. Lancet 1999;354:630-5.
16. Dawson CR. Review of eye infections with Chlamydia trachomatis. In: Mardh PA, et al. Chlamydia infections. Amsterdam: Elsevier Biomedical Press, 1982:71-81.
17. West S, Munoz B, Bobo L, et al. Nonocular chlamydia infection and risk of ocular reinfection after mass treatment in a trachoma hyperendemic area. Invest Ophthalmol Vis Sci 1993;34:3194-8.
18. Malaty R, Zaki S, Said ME, et al. Extraocular infections in children in areas with endemic trachoma. J Infect Dis 1981;143:853.
19. Dean D, Suchland R, Stamm W. Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. J Infect Dis 2000;182:909-16.
20. Bailey RL, Arullendran P, Whittle HC, et al. Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet 1993;342:453-o.
21. Dawson CR, Schachter J, Sallam S, et al. A comparison of oral azithromycin with topical oxytetracycline/polymyxin for the treatment of trachoma in children. Clin Infect Dis 1997;24:363-8.
22. Tabbara KF, Abu-el-Asrar A, al-Omar O, et al. Single-dose azithromycin in the treatment of trachoma. A randomized, controlled study. Ophthalmology 1996;103:842-6.
23. Taylor KI, Taylor HR. Distribution of azithromycin for the treatment of trachoma. Br J Ophthalmol 1999;83:134-5.
24. Thylefors B, Dawson CR, Jones BR, et al. A simple system for the assessment of trachoma and its complications. Bull World Health Organ 1987;65:477-483.
25. Solomon AW, Holland MJ, Burton MJ, et al. Strategies for control of trachoma: observational study with quantitative PCR. Lancet 2003;362:198-204.
26. Bowman RJ, Soma OS, Alexander N, et al. Should trichiasis surgery be offered in the village? A community randomised trial of village vs health centre-based surgery. Trop Med Int Health 2000;5:528-33.
27. Alemayehu W, Melese M, Bejiga A, et al. Surgery for trichiasis by ophthalmologists versus integrated eye care workers: a randomized trial. Ophthalmology 2004;111:578-84.
28. Bain DL, Lietman T, Rasmussen S, et al. Chlamydial genovar distribution after communitywide antibiotic treatment. J Infect Dis 2001;184:1581-8.